Explore more Norwegian companies →
COMPANY CARD COMPANY
PHARMA NORGE AS
Retail sale of other food
11,9 % EBIT margin
FINANCIALS
Financial statements and key figures
Company financial statements
Amount in NOK
| Financial statement item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Currency | NOK | NOK | NOK |
| Operating revenue | 63 089 966 | 55 161 814 | 40 477 581 |
| Operating profit | 7 496 799 | 15 456 739 | 8 374 989 |
| Net income | 8 089 249 | 14 178 962 | 6 784 721 |
| Equity | 29 269 478 | 35 482 697 | 32 469 334 |
| Total assets | 52 552 676 | 48 251 122 | 40 405 037 |
| EBIT margin | 11,9 % | 28,0 % | 20,7 % |
Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.
Show trend in NOK
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Sources and conversion basis
Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.
- 2025 · NOK · original-NOK · source version 3c096dfdbf72
- 2024 · NOK · original-NOK · source version 5f5c719f2654
- 2023 · NOK · original-NOK · source version db03c1eb39f3
Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.
Income statement13 entries with information
| Financial statement item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating revenue | |||
| Total sales revenue | 61 905 392 | 54 464 480 | 40 186 474 |
| Total operating revenue | 63 089 966 | 55 161 814 | 40 477 581 |
| Operating expenses | |||
| Wage costs | 8 125 688 | 9 964 977 | 9 580 785 |
| Total operating expenses | 55 593 166 | 39 705 075 | 32 102 593 |
| Operating profit | |||
| Operating income (EBIT) | 7 496 799 | 15 456 739 | 8 374 989 |
| Financial income | |||
| Total finance income | 1 120 788 | 489 426 | 387 387 |
| Financial expenses | |||
| Other interest expense | 282 404 | 102 501 | 16 065 |
| Total finance costs | 368 017 | 560 755 | 17 572 |
| Net finance result | 752 771 | -71 329 | 369 816 |
| Results and tax | |||
| Income before tax | 8 249 571 | 15 385 410 | 8 744 804 |
| Tax expense on ordinary income | 160 322 | 1 206 448 | 1 960 083 |
| Net income | 8 089 249 | 14 178 962 | 6 784 721 |
| Total comprehensive income | 8 089 249 | 14 178 962 | 6 784 721 |
Balance sheet13 entries with information
| Financial statement item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Financial fixed assets | |||
| Total non-current assets | 37 862 405 | 26 867 826 | 31 283 051 |
| Current assets | |||
| Total inventory | 5 730 678 | 2 160 923 | 1 215 136 |
| Total receivables | 8 643 904 | 14 718 501 | 6 562 803 |
| Total cash and cash equivalents | 315 689 | 4 503 873 | 1 344 048 |
| Total current assets | 14 690 271 | 21 383 297 | 9 121 986 |
| Total assets | 52 552 676 | 48 251 122 | 40 405 037 |
| Equity | |||
| Total paid-in equity | 23 064 700 | 23 064 700 | 23 069 100 |
| Total retained earnings | 6 204 778 | 12 417 997 | 9 400 234 |
| Total equity | 29 269 478 | 35 482 697 | 32 469 334 |
| Provisions and long-term liabilities | |||
| Total long-term liabilities | — | 1 206 448 | 0 |
| Current liabilities | |||
| Total current liabilities | 23 283 198 | 11 561 977 | 7 935 703 |
| Total liabilities | 23 283 198 | 12 768 425 | 7 935 703 |
| Total | |||
| Total equity and liabilities | 52 552 676 | 48 251 122 | 40 405 037 |
Reported dividends
| Financial year | Dividends – Income statement | Dividends – Balance sheet | Data date | Accounting scope |
|---|---|---|---|---|
| 2024 | 1 000 000 NOK | — | 26.10.2026 | Not stated |
| 2023 | 3 500 000 NOK | — | 26.10.2026 | Not stated |
| 2021 | 6 100 000 NOK | — | 26.10.2026 | Not stated |
| 2020 | 10 400 000 NOK | 1 800 000 NOK | 17.11.2026 | Company financial statements |
Income statement and balance sheet are separate accounting fields and must not be added together. “—” means missing information or an unconfirmed zero. The data date is the export date or the archive completion date.
Source: Brønnøysundregistrene
Executive salary
| Financial year | Reported CEO salary |
|---|---|
| 2020 | 900 000 NOK |
Source: Brønnøysundregistrene · Amount in NOK
REGISTRY INFORMATION
Company at a glance
- Industry
- 47.270 · Retail sale of other food Industry classification: Statistics Norway · CC BY 4.0
- Registered address
- Sørvåg, 8432 ALSVÅG
- Founded
- 01.10.2017
- Entity type
- Main entity
ADDRESS AND PROPERTY
Property information
Sørvåg, 8432 ALSVÅG
Companies at the same address
Available company cards
About the address match
Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.
REGISTERED ROLES
The people and companies behind it.
| Name | Role | Source date |
|---|---|---|
| Thomas Kristoffer StorvestreBorn 1987 | Chair of the board | 16.11.2026 |
| BOKHOLDERIET ASView role record | Accountant | 16.11.2026 |
| REVICOM ASView role record | Auditor | 16.11.2026 |
| Rune MeyerBorn 1968 | General manager | 16.11.2026 |
| ØKORÅD ØKSNES ASView role record | Accountant | 16.11.2026 |
Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.
YEAR-DATED OWNERSHIP
Reported shareholders.
As of 31 December 2025 · 4 of 4 available ownership entries
| Shareholder | Share / share class | Source date |
|---|---|---|
| GLOBAL PHARMA GROUP ASView ownership entryView share entries → | 88,40 % · Ordinary shares | 31.12.2025 |
| JAN-PETTER KROGHBorn 1956 · LANDEGODE | 6,48 % · Ordinary shares | 31.12.2025 |
| PHARMA NORGE ASView ownership entryView share entries → | 3,53 % · Ordinary shares | 31.12.2025 |
| INFUTURE INVEST ASView ownership entryView share entries → | 1,58 % · Ordinary shares | 31.12.2025 |
- GLOBAL PHARMA GROUP ASOrdinary shares88,40 %
- JAN-PETTER KROGHOrdinary shares6,48 %
- PHARMA NORGE ASOrdinary shares3,53 %
- INFUTURE INVEST ASOrdinary shares1,58 %
Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.
Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.
Previously reported ownership entries (35)
- 2024 · GLOBAL PHARMA GROUP AS · 56,09 %
- 2024 · LENA ELISABETH MEYER KROGH · 6,86 %
- 2024 · JAN-PETTER KROGH · 6,48 %
- 2024 · RUNE MEYER · 4,63 %
- 2024 · SAYL AS · 3,95 %
- 2024 · CHIMA AS · 3,77 %
- 2024 · PHARMA NORGE AS · 3,53 %
- 2024 · PS CAPITAL AS · 3,02 %
- 2024 · STORVESTREINVEST AS · 2,88 %
- 2024 · NOBELSYSTEM SCANDINAVIA AS · 1,78 %
- 2024 · FUN INVEST AS · 1,72 %
- 2024 · INFUTURE INVEST AS · 1,58 %
- 2024 · STORVESTRE SOLUTIONS AS · 1,44 %
- 2024 · CORVINA AS · 0,75 %
- 2024 · MORTEN PEDERSEN · 0,69 %
- 2024 · ANNEX INVEST AS · 0,48 %
- 2024 · NORDLYST AS · 0,34 %
- 2023 · GLOBAL PHARMA GROUP AS · 55,23 %
- 2023 · LENA ELISABETH MEYER KROGH · 7,75 %
- 2023 · RUNE MEYER · 7,07 %
- 2023 · JAN-PETTER KROGH · 6,86 %
- 2023 · SAYL AS · 3,95 %
- 2023 · CHIMA AS · 3,77 %
- 2023 · STORVESTREINVEST AS · 3,12 %
- 2023 · PS CAPITAL AS · 3,02 %
- 2023 · PHARMA NORGE AS · 2,02 %
- 2023 · FUN INVEST AS · 1,72 %
- 2023 · INFUTURE INVEST AS · 1,58 %
- 2023 · CORVINA AS · 0,75 %
- 2023 · NOBELSYSTEM SCANDINAVIA AS · 0,75 %
- 2023 · MORTEN PEDERSEN · 0,69 %
- 2023 · ANDREAS MEYER · 0,48 %
- 2023 · ANNEX INVEST AS · 0,41 %
- 2023 · STORVESTRE SOLUTIONS AS · 0,41 %
- 2023 · NORDLYST AS · 0,34 %
YEAR-DATED OWNERSHIP
Company share entries
The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.
YEAR-DATED OWNERSHIP
Indirect ownership
Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.
CONNECTIONS
Explore the ownership structure.
Directly reported ownership entries are shown first. Open the map to explore further.
Direct ownership entries without an interactive map
As of 31 December 2025 · 4 of 4 available ownership entries
| Shareholder | Share / share class | Source date |
|---|---|---|
| GLOBAL PHARMA GROUP ASView ownership entryView share entries → | 88,40 % · Ordinary shares | 31.12.2025 |
| JAN-PETTER KROGHBorn 1956 · LANDEGODE | 6,48 % · Ordinary shares | 31.12.2025 |
| PHARMA NORGE ASView ownership entryView share entries → | 3,53 % · Ordinary shares | 31.12.2025 |
| INFUTURE INVEST ASView ownership entryView share entries → | 1,58 % · Ordinary shares | 31.12.2025 |
Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.
Open interactive map for direct ownership entries
CONNECTIONS
Explore the ownership structure.
See owners and open further company levels, using the same year throughout the tree.
Click a company to open owners. Select i for details.